Drug recall D-0250-2021
Product
Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703, USA. Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad-382 210, India NDC 16729-472-08 (Vial NDC 16729-472-30)
Reason for recall
Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials
Lots and codes
Lot: M2013645 Exp. Aug. 2022
Recall details
- Recalling firm
- Accord Healthcare, Inc., Durham, NC
- Quantity
- 502 cartons
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 28, 2021
- Terminated
- February 8, 2022
Related products
- Glycopyrrolate – drug information
- NDC 16729-474 Glycopyrrolate · Glycopyrrolate .2 mg/mL · Accord Healthcare, Inc.,
- NDC 16729-471 Glycopyrrolate · Glycopyrrolate .2 mg/mL · Accord Healthcare, Inc.,
- NDC 16729-473 Glycopyrrolate · Glycopyrrolate .2 mg/mL · Accord Healthcare, Inc.,
- NDC 16729-472 Glycopyrrolate · Glycopyrrolate .2 mg/mL · Accord Healthcare, Inc.,